Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to 0.0%.

  • Marimed's Return on Capital Employed fell 400.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.02% for FY2024, which is 800.0% down from last year.
  • Per Marimed's latest filing, its Return on Capital Employed stood at 0.0% for Q3 2025, which was down 400.0% from 0.0% recorded in Q2 2025.
  • In the past 5 years, Marimed's Return on Capital Employed ranged from a high of 0.39% in Q2 2021 and a low of 0.0% during Q1 2025
  • For the 5-year period, Marimed's Return on Capital Employed averaged around 0.15%, with its median value being 0.11% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 17300bps in 2021, then plummeted by -2200bps in 2022.
  • Quarter analysis of 5 years shows Marimed's Return on Capital Employed stood at 0.29% in 2021, then plummeted by -42bps to 0.17% in 2022, then plummeted by -47bps to 0.09% in 2023, then crashed by -78bps to 0.02% in 2024, then tumbled by -75bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q3 2025, 0.0% for Q2 2025, and 0.0% during Q1 2025.